Regulus Therapeutics
RGLS
#7340
Rank
โ‚น54.64 B
Marketcap
โ‚น789.32
Share price
0.00%
Change (1 day)
485.06%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚น54.64 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of โ‚น54.64 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น50.71 B486.08%
2024โ‚น8.65 B301.56%
2023โ‚น2.15 B12.87%
2022โ‚น1.90 B-44.22%
2021โ‚น3.42 B-45.41%
2020โ‚น6.26 B370.01%
2019โ‚น1.33 B132.49%
2018โ‚น0.57 B-91.69%
2017โ‚น6.90 B-14.69%
2016โ‚น8.09 B-73.49%
2015โ‚น30.52 B-38.66%
2014โ‚น49.75 B160.8%
2013โ‚น19.07 B54.35%
2012โ‚น12.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚น9.287 T 16,894.99%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น3.225 T 5,803.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.681 T 21,276.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น23.883 T 43,603.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น9.011 T 16,390.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚น2.96 B-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น288.03 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น3.011 T 5,411.05%๐Ÿ‡บ๐Ÿ‡ธ USA